Zobrazeno 1 - 10
of 1 785
pro vyhledávání: '"Fryzek, J."'
Autor:
Yoshino T; Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Hooda N; Epidemiology, EpidStrategies, A Division of ToxStrategies, LLC., Rockville, MD, United States., Younan D; Center for Observational Research, Amgen Inc, Thousand Oaks, CA, United States., Muro K; Clinical Oncology Department, Aichi Cancer Center Hospital, Nagoya, Japan., Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Heinemann V; Medical Oncology Dept. and Comprehensive Cancer Center, LMU Klinikum der Universität München, Munich, Germany., O'neil BH; Oncology, Community Health Network, Indianapolis, IN, United States., Herrero FR; Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Peeters M; Molecular Imaging, Pathology, Radiotherapy, Oncology, University of Antwerp, Wilrijk, Belgium., Soeda J; Oncology Medical Affairs Department, Takeda Pharmaceutical Company Limited, Tokyo, Japan., Suh M; Epidemiology, EpidStrategies, A Division of ToxStrategies, LLC., Rockville, MD, United States., Reichert H; Epidemiology, EpidStrategies, A Division of ToxStrategies, LLC., Rockville, MD, United States., Mezzi K; Research and Development Department, Amgen Inc, Thousand Oaks, CA, United States., Fryzek J; Epidemiology, EpidStrategies, A Division of ToxStrategies, LLC., Rockville, MD, United States., Chia V; Center for Observational Research, Amgen Inc, Thousand Oaks, CA, United States., Rehn M; Medical Department, Amgen Inc, Thousand Oaks, CA, United States., Stintzing S; Department of Hematology, Oncology, and Cancer Immunology (CCM), Charité - Universitaetsmedizin Berlin, Berlin, Germany. Electronic address: sebastian.stintzing@charite.de.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113975. Date of Electronic Publication: 2024 Mar 01.
Autor:
Bylsma LC; EpidStrategies, A Division of ToxStrategies, LLC, Mission Viejo, CA, USA. lbylsma@epidstrategies.com., Pundole X; Amgen Inc., Thousand Oaks, CA, USA., Ju CH; Amgen Inc., Thousand Oaks, CA, USA., Hooda N; EpidStrategies, A Division of ToxStrategies, LLC, Mission Viejo, CA, USA., Movva N; EpidStrategies, A Division of ToxStrategies, LLC, Mission Viejo, CA, USA., Elkhouly E; Amgen Inc., Thousand Oaks, CA, USA., Bebb G; Amgen Inc., Thousand Oaks, CA, USA., Fryzek J; EpidStrategies, A Division of ToxStrategies, LLC, Mission Viejo, CA, USA., Martinez P; Amgen Inc., Thousand Oaks, CA, USA., Balasubramanian A; Amgen Inc., Thousand Oaks, CA, USA., Dingemans AC; Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Targeted oncology [Target Oncol] 2023 Nov; Vol. 18 (6), pp. 821-835. Date of Electronic Publication: 2023 Nov 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fored, C. M., Fryzek, J. P., Brandt, L., Nise, G., Sjögren, B., McLaughlin, J. K., Blot, W. J., Ekbom, A.
Publikováno v:
Occupational and Environmental Medicine, 2006 Feb 01. 63(2), 135-140.
Externí odkaz:
https://www.jstor.org/stable/27732686
Autor:
Broome CM; Division of Hematology, MedStar Georgetown University Hospital, Washington, DC, United States of America., Hooda N; EpidStrategies, Rockville, Maryland, United States of America., Su J; Sanofi, Cambridge, Massachussetts, United States of America., Jiang X; EpidStrategies, Rockville, Maryland, United States of America., Nicholson G; EpidStrategies, Rockville, Maryland, United States of America., Frankenfeld CL; EpidStrategies, Rockville, Maryland, United States of America., Iglesias-Rodriguez M; Sanofi, Cambridge, Massachussetts, United States of America., Fryzek J; EpidStrategies, Rockville, Maryland, United States of America., Patel P; Sanofi, Cambridge, Massachussetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2022 Dec 15; Vol. 17 (12), pp. e0276617. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022).
Autor:
Gillezeau C; Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai, New York, New York, United States of America., Movva N; EpidStrategies, Rockville, Maryland, United States of America., van Gerwen M; Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Department of Otolaryngology- Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America., Rabon-Stith K; AstraZeneca, Gaithersburg, Maryland, United States of America., Shire N; AstraZeneca, Gaithersburg, Maryland, United States of America., Brohawn PZ; AstraZeneca, Gaithersburg, Maryland, United States of America., Taioli E; Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai, New York, New York, United States of America., Fryzek J; EpidStrategies, Rockville, Maryland, United States of America.
Publikováno v:
PloS one [PLoS One] 2022 Aug 30; Vol. 17 (8), pp. e0271339. Date of Electronic Publication: 2022 Aug 30 (Print Publication: 2022).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rankin DA; Vanderbilt Epidemiology PhD Program, Vanderbilt University School of Medicine, 1161 21st Ave South, D7232 MCN, Nashville, TN 37232, USA., Haddadin Z; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Lipworth L; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Stahl AL; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Fryzek J; EpidStrategies, Rockville, MD, USA., Suh M; EpidStrategies, Rockville, MD, USA., Shepard DS; Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA., Varjabedian R; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Fernandez KN; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Salib S; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Villarreal J; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Bruce M; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., McHenry R; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Spieker AJ; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Nelson CB; Sanofi Pasteur, Swiftwater, PA, USA., Halasa NB; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Publikováno v:
Therapeutic advances in infectious disease [Ther Adv Infect Dis] 2022 Jul 18; Vol. 9, pp. 20499361221112171. Date of Electronic Publication: 2022 Jul 18 (Print Publication: 2022).